EUVIMEDEUVIMED entdecken
Open Access

A SWI/SNF-specific Ig-like domain, SWIFT, is a transcription factor binding platform

Siddhant U Jain iD, Kaylyn E Williamson iD, Alexander W Ying iD, Aasha M Turner, Ruidong Jerry Jiang iD, Shaunak Raval, Kevin So iD, Maxwell J Allison, Akshay Sankar iD, Daniel D Sáme Guerra iD, Yutong Lin iD, Zhe Jiang iD und 9 weitere

Science · 02.04.2026 · 392 (6793)

DOI: 10.1126/science.aeb3627 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Science, erschienen am 02.04.2026. Verfasst von Siddhant U Jain und 20 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pediatric Oncology, Dana-Farber Cancer Institute and Harvard Medical School, Boston, MA, USA. Hauptthemen laut MEDLINE: Chromosomal Proteins, Non-Histone, Proto-Oncogene Proteins, Trans-Activators, Transcription Factors. Die Arbeit wurde bisher 14-mal zitiert (Crossref) und nennt 153 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIA NIH HHS, NCI NIH HHS, NIGMS NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Mammalian switch/sucrose nonfermenting (mSWI/SNF) chromatin remodeling complexes modulate DNA accessibility and gene expression; however, their genomic targeting mechanisms remain incompletely understood. Here, we identify SWIFT [SWI/SNF immunoglobulin fold (Ig-fold) for transcription factor interactions], a conserved transcription factor (TF) binding domain on the SMARCD subunits. SWIFT is necessary and sufficient for direct engagement with the transactivation domain of the PU.1 TF. A single amino acid mutation disrupts PU.1-mSWI/SNF binding, impairs complex targeting, and attenuates oncogenic transcription and proliferation in PU.1-dependent human cancer cells. Dominant expression of the SWIFT domain in isolation sequesters TFs from mSWI/SNF and poisons TF-“addicted” cancer cells. Finally, TFs across diverse families interact with SMARCD paralog-specific SWIFT domains. These results define a major mechanism of cell type– and disease-specific mSWI/SNF chromatin targeting and inform approaches toward therapeutic modulation.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Chromosomal Proteins, Non-HistoneProto-Oncogene ProteinsTrans-ActivatorsTranscription FactorsHumansCell ProliferationChromatinChromatin Assembly and DisassemblyMutationProtein BindingProtein DomainsHEK293 Cells

Substanzen

ChromatinChromosomal Proteins, Non-HistoneProto-Oncogene ProteinsSWI-SNF-B chromatin-remodeling complexTrans-ActivatorsTranscription FactorsSMARCD1 protein, humanSMARCD2 protein, humanSMARCD3 protein, human

Autor:innen und Institutionen

  • Department of Pediatric Oncology, Dana-Farber Cancer Institute and Harvard Medical School, Boston, MA, USA.
  • Broad Institute of MIT and Harvard, Cambridge, MA, USA.
  • Department of Chemistry, Washington University in St. Louis, St. Louis, MO, USA.
  • Department of Chemistry, Princeton University, Princeton, NJ, USA.
  • Departments of Pathology and Immunology, School of Medicine, Washington University in St. Louis, St. Louis, MO, USA.
  • Department of Cell Biology, Harvard Medical School, Boston, MA, USA.

ORCID-Profile: Siddhant U Jain, Kaylyn E Williamson, Alexander W Ying, Ruidong Jerry Jiang, Kevin So, Akshay Sankar, Daniel D Sáme Guerra, Yutong Lin, Zhe Jiang, Henry W Rohrs, Cheryl F Lichti, Tom W Muir, Malvina Papanastasiou, Joao A Paulo, Steven P Gygi, Michael L Gross, Cigall Kadoch

Förderung

  • NIA NIH HHS
  • NCI NIH HHS
  • NIGMS NIH HHS
  • National Institutes of Health
  • Howard Hughes Medical Institute
  • American Association for Cancer Research
  • Pew Stewart Scholars in Cancer Research Award American Cancer Society Research Scholar Award
  • Mark Foundation For Cancer Research

Zitieren

APA

Jain, S. U., Williamson, K. E., Ying, A. W., Turner, A. M., Jiang, R. J., Raval, S., So, K., Allison, M. J., Sankar, A., Sáme Guerra, D. D., Lin, Y., Jiang, Z., Mashtalir, N., Rohrs, H. W., Lichti, C. F., Muir, T. W., Papanastasiou, M., Paulo, J. A., Gygi, S. P., …, & Kadoch, C. (2026). A SWI/SNF-specific Ig-like domain, SWIFT, is a transcription factor binding platform. Science, 392(6793). https://doi.org/10.1126/science.aeb3627

Vancouver

Jain SU, Williamson KE, Ying AW, Turner AM, Jiang RJ, Raval S, et al. A SWI/SNF-specific Ig-like domain, SWIFT, is a transcription factor binding platform. Science. 2026;392(6793). doi:10.1126/science.aeb3627

BibTeX
@article{Jain2026,
  author = {Jain, Siddhant U and Williamson, Kaylyn E and Ying, Alexander W and Turner, Aasha M and Jiang, Ruidong Jerry and Raval, Shaunak and So, Kevin and Allison, Maxwell J and Sankar, Akshay and Sáme Guerra, Daniel D and Lin, Yutong and Jiang, Zhe and Mashtalir, Nazar and Rohrs, Henry W and Lichti, Cheryl F and Muir, Tom W and Papanastasiou, Malvina and Paulo, Joao A and Gygi, Steven P and Gross, Michael L and Kadoch, Cigall},
  title = {A SWI/SNF-specific Ig-like domain, SWIFT, is a transcription factor binding platform},
  journal = {Science},
  year = {2026},
  volume = {392},
  number = {6793},
  doi = {10.1126/science.aeb3627}
}
Kostenlos starten →